Logo image of MTD

METTLER-TOLEDO INTERNATIONAL (MTD) Stock Fundamental Analysis

USA - NYSE:MTD - US5926881054 - Common Stock

1434.32 USD
-3.43 (-0.24%)
Last: 10/24/2025, 8:04:00 PM
1434.32 USD
0 (0%)
After Hours: 10/24/2025, 8:04:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to MTD. MTD was compared to 57 industry peers in the Life Sciences Tools & Services industry. MTD scores excellent on profitability, but there are some minor concerns on its financial health. MTD has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year MTD was profitable.
In the past year MTD had a positive cash flow from operations.
Each year in the past 5 years MTD has been profitable.
Each year in the past 5 years MTD had a positive operating cash flow.
MTD Yearly Net Income VS EBIT VS OCF VS FCFMTD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

The Return On Assets of MTD (24.40%) is better than 98.25% of its industry peers.
MTD's Return On Invested Capital of 39.61% is amongst the best of the industry. MTD outperforms 98.25% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MTD is significantly above the industry average of 14.94%.
Industry RankSector Rank
ROA 24.4%
ROE N/A
ROIC 39.61%
ROA(3y)25.04%
ROA(5y)23.93%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)41.86%
ROIC(5y)39.3%
MTD Yearly ROA, ROE, ROICMTD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K

1.3 Margins

MTD has a better Profit Margin (21.46%) than 94.74% of its industry peers.
In the last couple of years the Profit Margin of MTD has grown nicely.
MTD has a better Operating Margin (28.61%) than 100.00% of its industry peers.
In the last couple of years the Operating Margin of MTD has grown nicely.
Looking at the Gross Margin, with a value of 59.94%, MTD is in the better half of the industry, outperforming 78.95% of the companies in the same industry.
MTD's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 28.61%
PM (TTM) 21.46%
GM 59.94%
OM growth 3Y2.77%
OM growth 5Y3.56%
PM growth 3Y2.52%
PM growth 5Y3.63%
GM growth 3Y0.93%
GM growth 5Y0.74%
MTD Yearly Profit, Operating, Gross MarginsMTD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), MTD is creating value.
Compared to 1 year ago, MTD has less shares outstanding
MTD has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, MTD has a worse debt to assets ratio.
MTD Yearly Shares OutstandingMTD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
MTD Yearly Total Debt VS Total AssetsMTD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

MTD has an Altman-Z score of 10.71. This indicates that MTD is financially healthy and has little risk of bankruptcy at the moment.
MTD has a Altman-Z score of 10.71. This is amongst the best in the industry. MTD outperforms 92.98% of its industry peers.
MTD has a debt to FCF ratio of 2.58. This is a good value and a sign of high solvency as MTD would need 2.58 years to pay back of all of its debts.
MTD's Debt to FCF ratio of 2.58 is amongst the best of the industry. MTD outperforms 82.46% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.58
Altman-Z 10.71
ROIC/WACC3.82
WACC10.36%
MTD Yearly LT Debt VS Equity VS FCFMTD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

MTD has a Current Ratio of 1.12. This is a normal value and indicates that MTD is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of MTD (1.12) is worse than 84.21% of its industry peers.
MTD has a Quick Ratio of 1.12. This is a bad value and indicates that MTD is not financially healthy enough and could expect problems in meeting its short term obligations.
MTD has a worse Quick ratio (0.77) than 85.96% of its industry peers.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 0.77
MTD Yearly Current Assets VS Current LiabilitesMTD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

MTD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.37%, which is quite good.
Measured over the past years, MTD shows a quite strong growth in Earnings Per Share. The EPS has been growing by 12.53% on average per year.
Looking at the last year, MTD shows a small growth in Revenue. The Revenue has grown by 3.10% in the last year.
Measured over the past years, MTD shows a small growth in Revenue. The Revenue has been growing by 5.18% on average per year.
EPS 1Y (TTM)8.37%
EPS 3Y6.67%
EPS 5Y12.53%
EPS Q2Q%4.56%
Revenue 1Y (TTM)3.1%
Revenue growth 3Y1.37%
Revenue growth 5Y5.18%
Sales Q2Q%3.85%

3.2 Future

MTD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.10% yearly.
The Revenue is expected to grow by 3.43% on average over the next years.
EPS Next Y3.09%
EPS Next 2Y6.56%
EPS Next 3Y8.11%
EPS Next 5Y9.1%
Revenue Next Year3.3%
Revenue Next 2Y3.83%
Revenue Next 3Y4.33%
Revenue Next 5Y3.43%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MTD Yearly Revenue VS EstimatesMTD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B 4B 5B
MTD Yearly EPS VS EstimatesMTD Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20 40 60

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 35.07, the valuation of MTD can be described as expensive.
Based on the Price/Earnings ratio, MTD is valued a bit cheaper than 66.67% of the companies in the same industry.
When comparing the Price/Earnings ratio of MTD to the average of the S&P500 Index (26.91), we can say MTD is valued slightly more expensively.
MTD is valuated quite expensively with a Price/Forward Earnings ratio of 30.69.
71.93% of the companies in the same industry are more expensive than MTD, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.92. MTD is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 35.07
Fwd PE 30.69
MTD Price Earnings VS Forward Price EarningsMTD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MTD is valued a bit cheaper than the industry average as 70.18% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, MTD is valued a bit cheaper than 70.18% of the companies in the same industry.
Industry RankSector Rank
P/FCF 34.85
EV/EBITDA 25.84
MTD Per share dataMTD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 100 150

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
MTD has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)11.34
PEG (5Y)2.8
EPS Next 2Y6.56%
EPS Next 3Y8.11%

0

5. Dividend

5.1 Amount

No dividends for MTD!.
Industry RankSector Rank
Dividend Yield N/A

METTLER-TOLEDO INTERNATIONAL

NYSE:MTD (10/24/2025, 8:04:00 PM)

After market: 1434.32 0 (0%)

1434.32

-3.43 (-0.24%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)07-31 2025-07-31/amc
Earnings (Next)11-06 2025-11-06/amc
Inst Owners102.47%
Inst Owner Change-0.07%
Ins Owners0.42%
Ins Owner Change2.98%
Market Cap29.55B
Revenue(TTM)3.87B
Net Income(TTM)829.75M
Analysts71.58
Price Target1342.35 (-6.41%)
Short Float %3.49%
Short Ratio4.86
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.38%
Min EPS beat(2)2.78%
Max EPS beat(2)3.98%
EPS beat(4)4
Avg EPS beat(4)3.18%
Min EPS beat(4)1.02%
Max EPS beat(4)4.94%
EPS beat(8)6
Avg EPS beat(8)3.16%
EPS beat(12)10
Avg EPS beat(12)2.65%
EPS beat(16)14
Avg EPS beat(16)3.36%
Revenue beat(2)1
Avg Revenue beat(2)0.73%
Min Revenue beat(2)-0.18%
Max Revenue beat(2)1.63%
Revenue beat(4)3
Avg Revenue beat(4)1.01%
Min Revenue beat(4)-0.18%
Max Revenue beat(4)2.56%
Revenue beat(8)5
Avg Revenue beat(8)0.5%
Revenue beat(12)8
Avg Revenue beat(12)0.25%
Revenue beat(16)12
Avg Revenue beat(16)0.61%
PT rev (1m)0.9%
PT rev (3m)3.17%
EPS NQ rev (1m)-0.05%
EPS NQ rev (3m)1.68%
EPS NY rev (1m)0.13%
EPS NY rev (3m)1.06%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.18%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.03%
Valuation
Industry RankSector Rank
PE 35.07
Fwd PE 30.69
P/S 7.64
P/FCF 34.85
P/OCF 31.05
P/B N/A
P/tB N/A
EV/EBITDA 25.84
EPS(TTM)40.9
EY2.85%
EPS(NY)46.73
Fwd EY3.26%
FCF(TTM)41.16
FCFY2.87%
OCF(TTM)46.2
OCFY3.22%
SpS187.7
BVpS-12.56
TBVpS-58.08
PEG (NY)11.34
PEG (5Y)2.8
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 24.4%
ROE N/A
ROCE 48.24%
ROIC 39.61%
ROICexc 40.71%
ROICexgc 70.2%
OM 28.61%
PM (TTM) 21.46%
GM 59.94%
FCFM 21.93%
ROA(3y)25.04%
ROA(5y)23.93%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)41.86%
ROIC(5y)39.3%
ROICexc(3y)43.32%
ROICexc(5y)40.86%
ROICexgc(3y)78.59%
ROICexgc(5y)73.33%
ROCE(3y)50.98%
ROCE(5y)47.86%
ROICexgc growth 3Y5.41%
ROICexgc growth 5Y8.89%
ROICexc growth 3Y5.36%
ROICexc growth 5Y6.84%
OM growth 3Y2.77%
OM growth 5Y3.56%
PM growth 3Y2.52%
PM growth 5Y3.63%
GM growth 3Y0.93%
GM growth 5Y0.74%
F-Score7
Asset Turnover1.14
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.58
Debt/EBITDA 1.73
Cap/Depr 85.07%
Cap/Sales 2.69%
Interest Coverage 250
Cash Conversion 77.47%
Profit Quality 102.18%
Current Ratio 1.12
Quick Ratio 0.77
Altman-Z 10.71
F-Score7
WACC10.36%
ROIC/WACC3.82
Cap/Depr(3y)92.83%
Cap/Depr(5y)94.35%
Cap/Sales(3y)2.85%
Cap/Sales(5y)2.89%
Profit Quality(3y)97.94%
Profit Quality(5y)100.58%
High Growth Momentum
Growth
EPS 1Y (TTM)8.37%
EPS 3Y6.67%
EPS 5Y12.53%
EPS Q2Q%4.56%
EPS Next Y3.09%
EPS Next 2Y6.56%
EPS Next 3Y8.11%
EPS Next 5Y9.1%
Revenue 1Y (TTM)3.1%
Revenue growth 3Y1.37%
Revenue growth 5Y5.18%
Sales Q2Q%3.85%
Revenue Next Year3.3%
Revenue Next 2Y3.83%
Revenue Next 3Y4.33%
Revenue Next 5Y3.43%
EBIT growth 1Y4.27%
EBIT growth 3Y4.18%
EBIT growth 5Y8.92%
EBIT Next Year5.77%
EBIT Next 3Y6.15%
EBIT Next 5Y6.84%
FCF growth 1Y-1.24%
FCF growth 3Y2.57%
FCF growth 5Y11.3%
OCF growth 1Y-1.81%
OCF growth 3Y2.14%
OCF growth 5Y9.92%

METTLER-TOLEDO INTERNATIONAL / MTD FAQ

What is the ChartMill fundamental rating of METTLER-TOLEDO INTERNATIONAL (MTD) stock?

ChartMill assigns a fundamental rating of 5 / 10 to MTD.


What is the valuation status for MTD stock?

ChartMill assigns a valuation rating of 4 / 10 to METTLER-TOLEDO INTERNATIONAL (MTD). This can be considered as Fairly Valued.


Can you provide the profitability details for METTLER-TOLEDO INTERNATIONAL?

METTLER-TOLEDO INTERNATIONAL (MTD) has a profitability rating of 8 / 10.


What is the expected EPS growth for METTLER-TOLEDO INTERNATIONAL (MTD) stock?

The Earnings per Share (EPS) of METTLER-TOLEDO INTERNATIONAL (MTD) is expected to grow by 3.09% in the next year.